scholarly journals Heart failure in a district general hospital: are target doses of beta-blockers realistic?

QJM ◽  
2004 ◽  
Vol 97 (3) ◽  
pp. 133-139 ◽  
Author(s):  
P.A. Mehta ◽  
S. McDonagh ◽  
P.A. Poole-Wilson ◽  
R. Grocott-Mason ◽  
S.W. Dubrey
Heart ◽  
2016 ◽  
Vol 102 (Suppl 6) ◽  
pp. A12.1-A12
Author(s):  
Clare Coyle ◽  
Baltazar Nyathi ◽  
Simon Woldman ◽  
Mihir Sanghvi ◽  
Lindsey Iles ◽  
...  

2021 ◽  
Author(s):  
Małgorzata Dobrowolska ◽  
Paweł Miękus ◽  
Michał Świątczak ◽  
Grzegorz Raczak ◽  
Ludmiła Daniłowicz-Szymanowicz

2019 ◽  
Author(s):  
Hannah Sinclair ◽  
Melanie Ackrill ◽  
Hiliary Holdsworth ◽  
Chris Chase ◽  
Maxine Guillen ◽  
...  

2020 ◽  
Vol 15 (8) ◽  
pp. 1-9
Author(s):  
Tim Chester ◽  
Joanne Passmore

The use of brain natriuretic peptide biomarkers is often cited in guidelines for heart failure as part of diagnostic pathways for patients with suspected heart failure. The biomarker result helps clinicians to decide whether a patient goes on for transthoracic echocardiography. This article reviews the use and usefulness of these biomarkers in a district general hospital and its impact on patients admitted with suspected heart failure. For those considering its use, this paper may offer some insights into how to implement such tests for acute inpatients.


Sign in / Sign up

Export Citation Format

Share Document